Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

18 trials with published results (13%)

Research Maturity

69 completed trials (49% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.5%

5 terminated out of 141 trials

Success Rate

93.2%

+6.7% vs benchmark

Late-Stage Pipeline

11%

16 trials in Phase 3/4

Results Transparency

26%

18 of 69 completed with results

Key Signals

18 with results93% success

Data Visualizations

Phase Distribution

98Total
Not Applicable (33)
P 1 (17)
P 2 (32)
P 3 (10)
P 4 (6)

Trial Status

Completed69
Unknown30
Recruiting17
Not Yet Recruiting9
Active Not Recruiting5
Terminated5

Trial Success Rate

93.2%

Benchmark: 86.5%

Based on 69 completed trials

Clinical Trials (141)

Showing 20 of 20 trials
NCT06845618Recruiting

Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment

NCT06205589Phase 2Not Yet RecruitingPrimary

Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB

NCT06253715Phase 3Recruiting

Shortened Regimen for Drug-susceptible TB in Children

NCT07077213RecruitingPrimary

18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

NCT04752592Not ApplicableCompletedPrimary

Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB

NCT05285202Not ApplicableRecruitingPrimary

Clinic-based Versus Hotspot-focused Active TB Case Finding

NCT03512249Phase 2CompletedPrimary

Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence

NCT05556746Phase 2Active Not RecruitingPrimary

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB

NCT06057519Phase 3RecruitingPrimary

Pragmatic Optimized Rifampicin Trial

NCT07350356Completed

Bronchoscopic Role in Early Detection of Endobronchial Tuberculosis in Suspected Pulmonary Tuberculosis Patients.

NCT06441006Phase 2RecruitingPrimary

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

NCT07313995Not ApplicableNot Yet RecruitingPrimary

Digital Health Intervention to Improve TPT Uptake

NCT04919239Phase 2CompletedPrimary

Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)

NCT05455112Phase 2CompletedPrimary

Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis

NCT07271225Not ApplicableRecruitingPrimary

Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting

NCT06585358RecruitingPrimary

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

NCT06084715CompletedPrimary

The INSTITUT Study Tuberculosis Nutritional Support

NCT05048485CompletedPrimary

Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets

NCT04734652Phase 2Completed

INSTI's For The Management of HIV-associated TB

NCT05766267Phase 2Active Not RecruitingPrimary

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Scroll to load more

Research Network

Activity Timeline